Extended‐Spectrum β‐Lactamases

Clinical Infectious Diseases - Tập 41 Số s4 - Trang S273-S275 - 2005
Philip J. Turner1
1AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abraham EP, 1940, Nature, 146, 837, 10.1038/146837a0

10.1038/208239a0

Pitton JS, 1972, Rev Physiol Biochem Pharmacol, 65, 15

Neu HC, 1982, Ann Intern Med, 97, 408, 10.7326/0003-4819-97-3-408

Kliebe C, 1985, Antimicrob Agents Chemother, 28, 302, 10.1128/AAC.28.2.302

10.1128/CMR.14.4.933-951.2001

10.1128/AAC.48.1.1-14.2004

10.1046/j.1469-0691.2002.00401.x

Bradford PA, 1997, Antimicrob Agents Chemother, 41, 563, 10.1128/AAC.41.3.563

10.1056/NEJMra041359

10.1016/S0924-8579(99)00115-6

NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard-supplementary tables. NCCLS document M100-S13. Wayne, PA: NCCLS, 2003.

10.1086/320182

10.1016/j.diagmicrobio.2003.11.007

10.1111/j.1469-0691.2004.00957.x

10.1128/JCM.39.6.2206-2212.2001